These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10790769)

  • 1. Etiology of multiple sclerosis: role of superoxide dismutase.
    Lund-Olesen K
    Med Hypotheses; 2000 Feb; 54(2):321-2. PubMed ID: 10790769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation to G93Asuperoxide dismutase 1 in a motor neuron cell line model of amyotrophic lateral sclerosis: the role of glutathione.
    Tartari S; D'Alessandro G; Babetto E; Rizzardini M; Conforti L; Cantoni L
    FEBS J; 2009 May; 276(10):2861-74. PubMed ID: 19459941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superoxide dismutase may lead to cytoskeletal abnormalities and amyotrophic lateral sclerosis.
    Brenner S
    Ann Neurol; 2008 Sep; 64(3):357-8; author reply 358. PubMed ID: 18409199
    [No Abstract]   [Full Text] [Related]  

  • 4. Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis.
    Sala G; Beretta S; Ceresa C; Mattavelli L; Zoia C; Tremolizzo L; Ferri A; Carrì MT; Ferrarese C
    Neurochem Int; 2005 Feb; 46(3):227-34. PubMed ID: 15670639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese superoxide dismutase levels are elevated in a proportion of amyotrophic lateral sclerosis patient cell lines.
    McEachern G; Kassovska-Bratinova S; Raha S; Tarnopolsky MA; Turnbull J; Bourgeois J; Robinson B
    Biochem Biophys Res Commun; 2000 Jun; 273(1):359-63. PubMed ID: 10873611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superoxide dismutase: the cause of all amyotrophic lateral sclerosis?
    Matias-Guiu J; Galan L; Garcia-Ramos R; Barcia JA
    Ann Neurol; 2008 Sep; 64(3):356-7; author reply 358. PubMed ID: 18350588
    [No Abstract]   [Full Text] [Related]  

  • 7. The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn-superoxide dismutase mice.
    Gonzalez de Aguilar JL; Dupuis L; Oudart H; Loeffler JP
    Biomed Pharmacother; 2005 May; 59(4):190-6. PubMed ID: 15862714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimensional structure of the SF-36 in neurological patients.
    Dallmeijer AJ; Dekker J; Knol DL; Kalmijn S; Schepers VP; de Groot V; Lindeman E; Beelen A; Lankhorst GJ;
    J Clin Epidemiol; 2006 May; 59(5):541-3. PubMed ID: 16632144
    [No Abstract]   [Full Text] [Related]  

  • 9. [Etiology of multiple sclerosis].
    Laplaud DA; Confavreux C
    Rev Prat; 2006 Jun; 56(12):1306-12. PubMed ID: 16948218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infection by Epstein-Barr virus and multiple sclerosis].
    Alonso A; Egüés Olazábal N; Ayo Martín O
    Neurologia; 2006 Jun; 21(5):249-55. PubMed ID: 16788867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denaturational stress induces formation of zinc-deficient monomers of Cu,Zn superoxide dismutase: implications for pathogenesis in amyotrophic lateral sclerosis.
    Mulligan VK; Kerman A; Ho S; Chakrabartty A
    J Mol Biol; 2008 Nov; 383(2):424-36. PubMed ID: 18761352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence of hereditary factors in 2 diseases of unknown etiology: amyotrophic lateral sclerosis & multiple sclerosis].
    BARBIZET J
    Concours Med; 1958 Dec; 80(50):5369-72. PubMed ID: 13609147
    [No Abstract]   [Full Text] [Related]  

  • 13. Superoxide dismutase--applications and relevance to human diseases.
    Noor R; Mittal S; Iqbal J
    Med Sci Monit; 2002 Sep; 8(9):RA210-5. PubMed ID: 12218958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
    Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
    J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographic isolates: their role in neuroepidemiology.
    Kurland LT
    Adv Neurol; 1978; 19():69-82. PubMed ID: 742546
    [No Abstract]   [Full Text] [Related]  

  • 16. Initial manifestations and development of neurological dysfunctions in multiple sclerosis.
    Kalafatova O
    Acta Neurol (Napoli); 1988 Feb; 10(1 |||||||||||||):16-9. PubMed ID: 3254676
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of transition metals in the pathogenesis of amyotrophic lateral sclerosis.
    Vonk WI; Klomp LW
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1322-8. PubMed ID: 19021549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are multiple sclerosis and amyotrophic lateral sclerosis autoimmune disorders of endogenous vasoactive neuropeptides?
    Staines DR
    Med Hypotheses; 2008; 70(2):413-8. PubMed ID: 17582695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis.
    Centonze D; Rossi S; Finazzi-Agrò A; Bernardi G; Maccarrone M
    Int Rev Neurobiol; 2007; 82():171-86. PubMed ID: 17678961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New approaches in research of therapy of multiple sclerosis].
    Hemmer B; Cepok S; Nessler S; Sommer N
    Med Klin (Munich); 2001 Sep; 96 Suppl 1():23-8. PubMed ID: 11603112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.